SOURCE: Industrial Info Resources

Industrial Info Resources

October 08, 2015 06:30 ET

New Build Report: Pharmaceutical-Biotech Sector Plans 205 New Facilities With $18.5 Billion in Capital Investment Potential, an Industrial Info News Alert

SUGAR LAND, TX--(Marketwired - Oct 8, 2015) - Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- Scattered throughout North America are 205 reported new-facility builds in the Pharmaceutical-Biotech Industry, according to Industrial Info's Pharmaceutical-Biotech Online Database. The sites represent a potential total capital investment of $18.5 billion, which translates to a per-site average of about $90 million. The "potential" investment for each site includes initial construction, as well as any reported planned future expansions and subsequent phases.

Within this article: Details on key new-build projects in the Pharmaceutical-Biotech Industry, including those from major companies such as Novo Nordisk AS (NYSE:NVO) and Procter & Gamble (NYSE:PG).

For details, view the entire article by subscribing to Industrial Info's Premium Industry News, or browse other breaking industrial news stories at

Industrial Info Resources (IIR), with global headquarters in Sugar Land, Texas, five offices in North America and 10 international offices, is the leading provider of global market intelligence specializing in the industrial process, heavy manufacturing and energy markets. Industrial Info's quality-assurance philosophy, the Living Forward Reporting Principle™, provides up-to-the-minute intelligence on what's happening now, while constantly keeping track of future opportunities. To contact an office in your area, visit the "Contact Us" page.

Contact Information

  • Contact:
    William Ploch